Print  |  Close

A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177)


Active: Yes
Cancer Type: Colon/Rectal Cancer NCT ID:
Trial Phases: Phase III Protocol IDs: NCT02563002 (primary)
Eligibility: , Male and Female Study Type:
Study Sponsor: Merck Sharp & Dohme
NCI Full Details:

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.